1. Home
  2. UPC vs AZTR Comparison

UPC vs AZTR Comparison

Compare UPC & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universe Pharmaceuticals Inc.

UPC

Universe Pharmaceuticals Inc.

N/A

Current Price

$2.67

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.17

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPC
AZTR
Founded
1998
2014
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
1.9M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
UPC
AZTR
Price
$2.67
$0.17
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
12.7K
1.5M
Earning Date
01-01-0001
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.06
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$0.14
52 Week High
$11.00
$1.40

Technical Indicators

Market Signals
Indicator
UPC
AZTR
Relative Strength Index (RSI) 31.84 35.69
Support Level $2.66 $0.15
Resistance Level $3.97 $0.32
Average True Range (ATR) 0.20 0.02
MACD -0.03 0.00
Stochastic Oscillator 4.82 30.82

Price Performance

Historical Comparison
UPC
AZTR

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: